Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

Scotland is fortunate to have an abundance of world class higher education facilities within a relatively small geographic space. They innovate ...

CureVac NV (CVAC) reports a robust financial position with a significant licensing agreement with GSK, despite challenges in ...

Strategic Milestone Achievement and Increased Financial Discipline Underscore Year of Corporate TransformationCompleted enrollment of Part B of Phase 1 glioblastoma study with investigational ...

Cleantech leader Aymium defeated a challenge by Stora Enso to one of Aymium's patents (European Patent EP2697185) that provides exclusive rights to produce, sell and use bio-based materials for ...

Yamaha might have discontinued the radical Niken GT from America, but this three-wheeled motorcycle is still selling across ...

PLC ("TC BioPharm" or the "Company")  a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced receipt of a ...

CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announces that U.S. Patent No. 12,270,055 was issued today by the United States Patent and Trademark Office. EMBLEM ...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical ...

Algernon Pharmaceuticals (AGNPF) announces that it has received a notice of allowance from the European Patent Office, EPO, for patent ...

Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it ...

Europe’s Unified Patent Court has ordered Kodak to stop selling its Sonora XTRA-3 process-free plates in Germany in a ruling handed down on 2 April, which Kodak is appealing.